Clinical trial
Lycopene or Omega-3 Fatty Acid Nutritional Supplements in Treating Patients With…
NCT00402285 · University of California, San Francisco, Other · Completed
Key facts
| NCT number | NCT00402285 |
|---|---|
| Title | Lycopene or Omega-3 Fatty Acid Nutritional Supplements in Treating Patients With Stage I or Stage II Prostate Cancer |
| Official title | The Molecular Effects of Nutrition Supplements (MENS) Prostate Study |
| Lead sponsor | University of California, San Francisco, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Dietary Supplement, Other |
| Interventions | lycopene supplement, fish oil supplement, Placebo |
| Enrollment | 84 |
| Start date | Apr 1, 2003 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | Nov 22, 2006 |
| Last update posted | Jan 1, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: